A. Spyridonidis

706 total citations
20 papers, 434 citations indexed

About

A. Spyridonidis is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, A. Spyridonidis has authored 20 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 7 papers in Hematology and 4 papers in Oncology. Recurrent topics in A. Spyridonidis's work include Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (2 papers) and Cancer Research and Treatments (2 papers). A. Spyridonidis is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Acute Myeloid Leukemia Research (2 papers) and Cancer Research and Treatments (2 papers). A. Spyridonidis collaborates with scholars based in Germany, Greece and Israel. A. Spyridonidis's co-authors include Jürgen Finke, Hartmut Bertz, Robert Zeiser, Carsten Grüllich, Ofir Cohen, Anna Sansone, Chryssostomos Chatgilialoglu, Kyriakos E. Kypreos, Carla Ferreri and Περιστέρα-Ιωάννα Πετροπούλου and has published in prestigious journals such as Blood, Annals of Oncology and Leukemia.

In The Last Decade

A. Spyridonidis

20 papers receiving 429 citations

Peers

Countries citing papers authored by A. Spyridonidis

Since Specialization

Citations

This map shows the geographic impact of A. Spyridonidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Spyridonidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Spyridonidis more than expected).

Fields of papers citing papers by A. Spyridonidis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Spyridonidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Spyridonidis. The network helps show where A. Spyridonidis may publish in the future.

Co-authorship network of co-authors of A. Spyridonidis

This figure shows the co-authorship network connecting the top 25 collaborators of A. Spyridonidis. A scholar is included among the top collaborators of A. Spyridonidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Spyridonidis. A. Spyridonidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Brentuximab vedotin in combination with or without donor lymphocyte infusion for patients with Hodgkin lymphoma after allogeneic stem cell transplantation	Bone Marrow Transplantation	Panagiotis Tsirigotis, Ivetta Danylesko et al.	21
2	Fatty acid-related modulations of membrane fluidity in cells: detection and implications	Free Radical Research	Giuseppe Maulucci, Ofir Cohen et al.	134
3	Specific abnormalities versus number of abnormalities and cytogenetic scoring systems for outcome prediction after allogeneic hematopoietic SCT for myelodysplastic syndromes	Bone Marrow Transplantation	Charikleia Kelaïdi, Ifigeneia Tzannou et al.	5
4	Irradiated Mononuclear Cells Express Significant In Vitro Cytotoxic Activity: Promise for In Vivo Clinical Efficacy of Irradiated Mismatched Donor Lymphocytes Infusion	Immunotherapy	Panagiotis Tsirigotis, Igor Resnick et al.	5
5	Identification of a novel HLA-G+ regulatory population in blood: expansion after allogeneic transplantation and de novo HLA-G expression at graft-versus-host disease sites	Haematologica	Maria Themeli, Maria Liga et al.	12
6	CT60 single-nucleotide polymorphism as a surrogate marker for donor lymphocyte infusion outcome after allogeneic cell transplantation for acute leukemia	Bone Marrow Transplantation	Yannis Metaxas, Hartmut Bertz et al.	13
7	Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet	Transplant Infectious Disease	Eleni D. Lagadinou, Markos Marangos et al.	20
8	Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia	Leukemia	Maria Themeli, Miguel Waterhouse et al.	28
9	A fludarabine, thiotepa reduced toxicity conditioning regimen designed specifically for allogeneic second haematopoietic cell transplantation after failure of previous autologous or allogeneic transplantation	Bone Marrow Transplantation	Carsten Grüllich, Hartmut Bertz et al.	20
10	Evaluation of immunomodulatory treatment based on conventional and lineage-specific chimerism analysis in patients with myeloid malignancies after myeloablative allogeneic hematopoietic cell transplantation	Leukemia	Robert Zeiser, A. Spyridonidis et al.	55
11	Donor lymphocyte infusions for multiple myeloma: clinical results and novel perspectives	Bone Marrow Transplantation	Robert Zeiser, Hartmut Bertz et al.	37
12	Evidence for a graft-versus-mast-cell effect after allogeneic bone marrow transplantation	Bone Marrow Transplantation	A. Spyridonidis, A. Thomas et al.	18
13	Paraneoplastic cerebellar degeneration and nephrotic syndrome preceding Hodgkin's disease: case report and review of the literature	European Journal Of Haematology	A. Spyridonidis, Franz X. Glocker et al.	7
14	Nosocomial diarrhea caused by Salmonella derby infection in two patients on chemotherapy	Clinical Microbiology and Infection	Bernhard Steinbrückner, A. Spyridonidis et al.	3
15	Life-threatening hyperchloraemic acidosis in an azotaemic patient with normal serum creatinine	Nephrology Dialysis Transplantation	A. Spyridonidis	1
16	Proliferation and Survival of Mammary Carcinoma Cells Are Influenced by Culture Conditions Used for Ex Vivo Expansion of CD34+Blood Progenitor Cells	Blood	A. Spyridonidis, Wanja M. Bernhardt et al.	10
17	Proliferation and Survival of Mammary Carcinoma Cells Are Influenced by Culture Conditions Used for Ex Vivo Expansion of CD34+Blood Progenitor Cells	Blood	A. Spyridonidis, Wanja M. Bernhardt et al.	2
18	Minimal residual disease in autologous hematopoietic harvests from breast cancer patients	Annals of Oncology	A. Spyridonidis, Wanja M. Bernhardt et al.	6
19	Purging of Mammary Carcinoma Cells During Ex Vivo Culture of CD34+ Hematopoietic Progenitor Cells With Recombinant Immunotoxins	Blood	A. Spyridonidis, Mathias Schmidt et al.	4
20	Purging of Mammary Carcinoma Cells During Ex Vivo Culture of CD34+ Hematopoietic Progenitor Cells With Recombinant Immunotoxins	Blood	A. Spyridonidis, Mathias Schmidt et al.	33

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact